Focal liver lesions in the setting of chronic liver disease

Merrill, Christina; Samuel, Anna S.; Barr, Richard G.; Wilson, Stephanie R.

doi:10.1016/b978-0-323-87479-3.00022-3

Multiparametric Ultrasound for the Assessment of Diffuse Liver Disease 2024

DOI: 10.1016/b978-0-323-87479-3.00022-3

|View full text |Cite

Focal liver lesions in the setting of chronic liver disease

Christina Merrill¹,

Anna S. Samuel²,

Richard G. Barr³

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Cancer death scenario: A brief concept on cancer related deaths

Raj,

Priya,

Singh

et al. 2024

IJPP

View full text Add to dashboard Cite

A mass of aberrant tissue that has grown as a result of excessive, autonomous, and uncontrolled cell proliferation is known as a cancer, neoplasm, or tumour. The loss of the cell's regulatory system and an aberrant chromosome or DNA mutation are both contributing factors to this condition. Neoplasm refers to new growth, and neoplasia refers to the process of cell proliferation. Oncology, which derives from the Greek words oncos, which means tumour, and logos, which means study, is the area of medicine that deals with the thorough examination of a neoplasm (tumour), as well as its growth, diagnosis, and treatment. Generally, all malignant tumours are referred to as cancer. A safe and effective alternative for the treatment of tumours that produce granular exocytosis (perforin and granzymes) and death and do not respond to conventional treatment, cancer immunotherapy has emerged in recent years as two primary pathways implicated in CL-mediated tumour cell death. Treatments, including various ligand kinds, are briefly discussed before a comprehensive analysis of high aggressiveness. New immune modulators include immunotherapy, CTLA-4 blockers (cytotoxic T-lymphocytes unsupervised), and drugs involved in cell death during immunological cancer. Due to metastases from neighbouring organs and coexisting conditions such cirrhosis and chronic hepatitis, primary liver cancer is challenging to precisely diagnose after death. By altering the base rate or by influencing risk modification by sex and age, trends in diagnostic accuracy may have an impact on estimates of the radiation risk for liver cancer.

show abstract

Cancer death scenario: A brief concept on cancer related deaths

Raj,

Priya,

Singh

et al. 2024

IJPP

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Focal liver lesions in the setting of chronic liver disease

Cited by 1 publication

References 27 publications

Cancer death scenario: A brief concept on cancer related deaths

Cancer death scenario: A brief concept on cancer related deaths

Contact Info

Product

Resources

About